Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds
Eli Lilly has been as acquisitive as ever, striking five new deals in the past week alone. On Tuesday, the company dove into the deep end of vaccine development with three separate buys in the space. Outside of vaccines, Lilly scooped up preclinical biotech Engage Bio for $202 million and teamed up with AI company Collaborative Drug Discovery for its life sciences data management solutions.
These deals and Lilly’s skyrocketing revenue pushed the Indianapolis-based company to the top of IDEA Pharma’s list of best inventors and innovators.
Lilly also continues to make headlines for its…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.